Immunocompetent children account for the majority of complications in childhood herpes zoster

Journal of Infectious Diseases

Volumn 196, Issue 10, 2007, Pages 1455-1458

  Grote, Veit ^a,b   Von Kries, Rüdiger ^a   Rosenfeld, Eva ^a   Belohradsky, Bernd H ^b   Liese, Johannes ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HERPES ZOSTER; HERPES ZOSTER ENCEPHALITIS; HERPES ZOSTER OPHTHALMICUS; HERPES ZOSTER OTICUS; HOSPITALIZATION; HUMAN; IMMUNOCOMPETENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN INFECTION; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; CHILD HOSPITALIZATION; GERMANY; PRESCHOOL CHILD; QUESTIONNAIRE; STATISTICS;

ADOLESCENT; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; FEMALE; GERMANY; HERPES ZOSTER; HOSPITALIZATION; HUMANS; IMMUNOCOMPETENCE; INCIDENCE; MALE; QUESTIONNAIRES;

EID: 38449115102     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522631     Document Type: Article

References (15)

1. Gnann JW, Whitley RJ. Herpes zoster. N Engl J Med 2002; 347:340-6.
2. Wurzel CL, Kahan J, Heitler M, Rubin LG. Prognosis of herpes zoster in healthy children. Am J Dis Child 1986; 140:477-8.
3. Guess HA, Broughton DD, Melton LJ, Kurland LT. Epidemiology of herpes-zoster in children and adolescents - a population-based study. Pediatrics 1985; 76:512-7.
4. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965; 58:9-20.
5. Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001; 20:121-4.
6. Rogers RS 3rd, Tindall JP. Herpes zoster in children. Arch Dermatol 1972; 106:204-7.
7. Oxman MN. Clinical manifestations of herpes zoster. In: Arvin AM, Gershon AA, eds. Varicella-zoster virus: virology and clinical management. Cambridge: Cambridge University Press, 2000:246-75.
8. Koskiniemi M, Piiparinen H, Rantalaiho T, et al. Acute central nervous system complications in varicella zoster virus infections. J Clin Virol 2002; 25:293-301.
9. Opstelten W, Zaal MJ. Managing ophthalmic herpes zoster in primary care. BMJ 2005; 331:147-51.
10. Cobo LM, Foulks GN, Liesegang T, et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology 1986; 93:763-70.
11. Furuta Y, Ohtani F, Aizawa H, Fukuda S, Kawabata H, Bergstrom T. Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J 2005; 24:97-101.
12. Devriese PP, Moesker WH. The natural history of facial paralysis in herpes zoster. Clin Otolaryngol Allied Sci 1988; 13:289-98.
13. Petursson G, Helgason S, Gudmundsson S, Sigurdsson JA. Herpes zoster in children and adolescents. Pediatr Infect Dis J 1998; 17:905-8.
14. Coplan P, Black S, Rojas C, et al. Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease. Pediatr Infect Dis J 2001; 20:641-5.
15. Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine: a study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 1991; 325:1545-50.